Skip to content

Atopic Dermatitis in Clinical Practice Patient Reported Outcome(PRO)Fact-Finding Study

Atopic Dermatitis in Clinical Practice Patient Reported Outcome(PRO)Fact-Finding Study - AD PRO Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000058505
Enrollment
400
Registered
2025-07-18
Start date
2025-07-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic Dermatitis

Interventions

None listed

Sponsors

Otsuka Pharmaceutical Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Physicians who meet all of the following selection criteria will be included in this study Outpatient services, Treated at least 10 patients with atopic dermatitis in the last month, The individual's consent to participate in the research is obtained

Exclusion criteria

Exclusion criteria: No exclusion criteria are set

Design outcomes

Primary

MeasureTime frame
Usage of PRO, Demographic characteristics

Secondary

MeasureTime frame
Impact of using PRO, Notes on the use of PRO, Elements needed to promote PRO use/information needs

Countries

Japan

Contacts

Public ContactYasuhito Konishi

Otsuka Pharmaceutical Co., Ltd. Medical Affairs Department

Konishi.Yasuhito@otsuka.jp0367171400

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026